The estimated Net Worth of Derek A Bertocci is at least 13.7 百万$ dollars as of 1 September 2020. Mr. Bertocci owns over 30,100 units of Guardant Health Inc stock worth over 158,497$ and over the last 16 years he sold GH stock worth over 11,381,715$. In addition, he makes 2,129,610$ as Chief Financial Officer at Guardant Health Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Bertocci GH stock SEC Form 4 insiders trading
Derek has made over 10 trades of the Guardant Health Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 30,100 units of GH stock worth 2,827,594$ on 1 September 2020.
The largest trade he's ever made was selling 42,548 units of Guardant Health Inc stock on 19 August 2019 worth over 4,254,800$. On average, Derek trades about 8,516 units every 127 days since 2009. As of 1 September 2020 he still owns at least 6,373 units of Guardant Health Inc stock.
You can see the complete history of Mr. Bertocci stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Derek Bertocci biography
Derek Bertocci CPA is no longer serves as Chief Financial Officer of the Company effective 12/4/2020. Prior to joining us, Mr. Bertocci served as Senior Vice President and Chief Financial Officer of Achaogen Inc. from February 2014 to December 2015. Prior to that, Mr. Bertocci was Senior Vice President and Chief Financial Officer of Accuray Incorporated, a publicly traded radiation oncology company, from January 2009 to September 2013. From October 2006 through December 2008, Mr. Bertocci served as the Chief Financial Officer of BioForm Medical, Inc., a publicly traded medical aesthetics company. From June 2005 to July 2006, he was Chief Financial Officer of Laserscope, a publicly traded provider of lasers and fiber optic devices for urology and aesthetic surgery. Prior to that, Mr. Bertocci spent a number of years in various roles at VISX Incorporated, a publicly traded provider of systems for laser vision correction surgery, including as Chief Financial Officer from March 2004 to May 2005 and Vice President and Controller from 1998 to March 2004. Mr. Bertocci holds a B.A. degree from Stanford University and an M.B.A. degree from the University of Southern California. Mr. Bertocci is also a Certified Public Accountant (inactive)
What is the salary of Derek Bertocci?
As the Chief Financial Officer of Guardant Health Inc, the total compensation of Derek Bertocci at Guardant Health Inc is 2,129,610$. There are 1 executives at Guardant Health Inc getting paid more, with Michael Wiley having the highest compensation of 2,216,070$.
How old is Derek Bertocci?
Derek Bertocci is 66, he's been the Chief Financial Officer of Guardant Health Inc since 2016. There are 1 older and 13 younger executives at Guardant Health Inc. The oldest executive at Guardant Health Inc is Stanley Meresman, 73, who is the Independent Director.
What's Derek Bertocci's mailing address?
Derek's mailing address filed with the SEC is 505, Penobscot Drive, Redwood City, San Mateo County, California, 94063, United States.
Insiders trading at Guardant Health Inc
Over the last 6 years, insiders at Guardant Health Inc have traded over 2,653,630,540$ worth of Guardant Health Inc stock and bought 2,438,210 units worth 45,173,576$ . The most active insiders traders include Bluebird (Cayman) Ltd Softb...、Bluebird (Cayman) Ltd Svf E...、Helmy Eltoukhy. On average, Guardant Health Inc executives and independent directors trade stock every 6 days with the average trade being worth of 2,415,822$. The most recent stock trade was executed by Kumud Kalia on 9 September 2024, trading 6,545 units of GH stock currently worth 162,774$.
What does Guardant Health Inc do?
we believe conquering cancer is a big data problem. that’s why we built the world’s leading comprehensive liquid biopsy. this non-invasive tool for accessing and sequencing tumor dna is used by thousands of oncologists to help tens of thousands of advanced cancer patients. we believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. we’re working on some exciting ones, including in early detection, where the impact on patients can be profound. we’ve raised more than $500 million from investors including sequoia capital, khosla ventures, orbimed, and softbank.
What does Guardant Health Inc's logo look like?
Complete history of Mr. Bertocci stock trades at Accuray Inc、Guardant Health Inc
Guardant Health Inc executives and stock owners
Guardant Health Inc executives and other stock owners filed with the SEC include:
-
Michael Wiley,
Chief Legal Officer -
Derek Bertocci,
Chief Financial Officer -
Helmy Eltoukhy,
Chief Executive Officer, Director -
AmirAli Talasaz,
Chairman of the Board, President, Chief Operating Officer -
John G. Saia,
Sr. VP, Gen. Counsel & Corp. Sec. -
Michael J. Wiley,
Head of Corp. Affairs -
Dr. Richard B. Lanman,
Advisor -
Bahija Jallal,
Independent Director -
Ian Clark,
Lead Independent Director -
Stanley Meresman,
Independent Director -
Samir Kaul,
Independent Director -
Dr. AmirAli Talasaz Ph.D.,
Co-CEO & Director -
Dr. Helmy Eltoukhy Ph.D.,
Co-Founder, Co-CEO & Chairman -
Lynn Lewis,
IR Contact Officer -
Vijaya Gadde,
Director -
Kumud Kalia,
Chief Information Officer -
Dr. Richard B. Lanman M.D.,
Advisor -
Steven Collora,
VP of Sales -
Daniel Simon,
Sr. VP of Biopharma Bus. Devel. -
Andy Ament,
Sr. VP of Operations -
Mark Jacobstein,
Chief User Engagement Officer -
Amelia Merrill,
VP of People -
Michael Bell,
Chief Financial Officer -
Richard B. Lanman,
Chief Medical Officer -
Terilyn J. Monroe,
Chief People Officer -
Musa Tariq,
Director -
Craig Eagle,
Chief Medical Officer -
Meghan V. Joyce,
Director -
Group Capital Ltd Softbank ...,
-
Us (Ttgp), Ltd.Sc U.S. Vent...,
-
Vision Fund (Aiv M1) L.P.Sb...,
-
Beta Pte. Ltd.Temasek Life ...,
-
Advisors Llc Orbimed,
10% owner -
Ultimate General Partner Se...,
-
Ventures Iv, L.P.Khosla Ven...,
-
Ultimate General Partner X,...,
-
Bluebird (Cayman) Ltd Softb...,
-
Dipchand Nishar,
Director -
Aaref Hilaly,
Director -
John G. Saia,
Chief Legal Officer -
Bluebird (Cayman) Ltd Svf E...,
-
Chris Freeman,
Chief Commercial Officer -
Myrtle S Potter,
Director -
Steve E. Krognes,
Director -
Michael Brian Bell,
Chief Financial Officer -
Amelia Merrill,
SVP, People -
Medina Manuel Hidalgo,
Director -
Darya Chudova,
Chief Technology Officer -
Ines Dahne Steuber,
Chief Operating Officer